Experiments for taxon Streptomyces aureofaciens (STREPTOMYCETACEAE)

Experiments (26 results)

Filters
Worktypes (16)
9
9
4
3
2
2
2
2
1
1
1
1
1
1
1
1
No match
Pharmacology (3)
1
1
24
No match
Compounds (23)
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Organisms (13)
8
3
2
2
2
2
1
1
1
1
1
1
1
No match
26 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
997350
MICROBIAL TRANSFORMATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
MYCOPHENOLIC ACID
997351
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
MYCOPHENOLIC ACID-7-O-BETA-D-GLUCOSIDE
334090
MICROBIAL TRANSFORMATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
CHRYSAZIN
614333
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
TETRACYCLINE
334087
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
ANTHRAQUINONE,1-HYDROXY: 2-O-BETA-D-GLUCOSIDE
329229
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
TETRACYCLINE,CHLOR:
334091
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
ANTHRAQUINONE,1-HYDROXY: 8-O-BETA-D-GLUCOSIDE
1008936
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
MYCOPHENOLIC ACID GLUCOSIDE
848400
PHARMACOLOGY OF COMPOUND - IN VITRO
IMMUNOLOGIC EFFECTS(UNSPECIFIED)
Streptomyces aureofaciens (STREPTOMYCETACEAE)
PURPURIN-2-BETA-D-GLUCOSIDE
334088
MICROBIAL TRANSFORMATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
QUINIZARIN
868815
IDENTIFICATION IN BY TLC
Streptomyces aureofaciens (STREPTOMYCETACEAE)
AFLATOXIN B-2
848398
MICROBIAL TRANSFORMATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
PURPURIN
1008935
PATENT DESCRIBEDMICROBIAL TRANSFORMATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
MYCOPHENOLIC ACID
334093
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
ANTHRAQUINONE,2-HYDROXY: 6-O-BETA-D-GLUCOSIDE
46126
MICROBIAL TRANSFORMATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
KESSYL ALCOHOL,ALPHA:
848399
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
PURPURIN-2-BETA-D-GLUCOSIDE
1190956
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Streptomyces aureofaciens (STREPTOMYCETACEAE)
STREPTOMYCES ANTIBIOTIC WS-1228-A
334089
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
ANTHRAQUINONE,1-HYDROXY: 4-O-BETA-D-GLUCOSIDE
46127
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
KESSANE-2-BETA-7-DIOL
46125
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Streptomyces aureofaciens (STREPTOMYCETACEAE)
KESSYL-GLYCOL
334092
MICROBIAL TRANSFORMATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
ANTHRAFLAVIN
46124
MICROBIAL TRANSFORMATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
KESSYL ALCOHOL,ALPHA:
334086
MICROBIAL TRANSFORMATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
ALIZARIN
909431
STRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
VACIDIN AGEDAMYCIN
601836
ISOLATION AND IDENTIFICATION OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
TETRACYCLINE,CHLOR:CLINDAMYCIN
321070
ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION AND IDENTIFICATION OFREVIEW OF
Streptomyces aureofaciens (STREPTOMYCETACEAE)
TETRACYCLINE